T0	Participants 34 63	children with cystic fibrosis
T1	Participants 628 661	children and adolescents with CF.
T2	Participants 744 921	44 CF patients (aged 7-19 y; 20 males) who were randomly assigned to receive magnesium (n = 22; 300 mg/d) or placebo (n = 22) for 8 wk with a 4-wk washout period between trials.